Apple vs AstraZeneca: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Apple and AstraZeneca side by side

1. 1913AstraZeneca

   Astra AB Founded in Södertälje, Sweden

   400 doctors and apothecaries establish Astra AB to manufacture pharmaceuticals for the Swedish market, creating the foundation for what would become one of Europe's largest drug companies.

2. 1976Apple

   Apple is founded by Steve Jobs, Steve Wozniak, and Ronald Wayne, turning an early personal-computer board into a company with a product and a market.

   Steve Jobs, Steve Wozniak, and Ronald Wayne founded Apple in 1976, when personal computing was still a hobbyist market.

3. 1977Apple

   The Apple II launches and gives the young company an expandable personal computer for schools, homes, and small businesses.

   The Apple II turned a garage project into a business. Color graphics, expansion slots and a consumer-friendly design carried it into schools, homes and small offices, giving Apple a revenue base years before the Macintosh.

4. 1980Apple

   Apple completes its initial public offering in December 1980, raising capital and turning personal computing into a public-market story.

   The December 1980 IPO gave Apple public-market capital and made personal computing look like a serious commercial category. It also raised the pressure to professionalize management, distribution and product planning as the company outgrew its founding team.

5. 1984Apple

   The Macintosh introduces a graphical interface and mouse-driven computing to a broad audience at a $2,495 launch price.

   The Macintosh brought a graphical interface and a mouse to a mass-market computer and defined Apple's design identity.

6. 1993AstraZeneca

   Zeneca Group Spun Off from ICI

   Imperial Chemical Industries demerges its pharmaceuticals and agrochemicals businesses to form Zeneca Group PLC, with initial products including Zestril, Nolvadex, and Zoladex generating approximately $3.2 billion in annual sales.

7. 1997Apple

   Apple completes the NeXT acquisition, bringing Steve Jobs back and supplying the operating-system foundation for the years that followed.

   Apple's NeXT acquisition brought Steve Jobs back when the company was financially weak and unfocused.

8. 1999AstraZeneca

   Astra and Zeneca Merge to Form AstraZeneca

   The all-share merger of equals completes on 6 April 1999, creating AstraZeneca PLC.

9. 2000AstraZeneca

   Nexium Launch Replaces Prilosec

   AstraZeneca launches Nexium (esomeprazole), the single-isomer successor to Losec/Prilosec, in Europe in 2000 and in the United States in 2001 after FDA approval on 20 February 2001.

10. 2001Apple

    Apple introduces the iPod on October 23, 2001, a 5GB music player priced at $399 that held about 1,000 songs.

    The iPod put a hard-drive music library in a pocket at $399 and went on sale on November 10, 2001.

11. 2006AstraZeneca

    Acquisition of Cambridge Antibody Technology

    AstraZeneca agrees in May 2006 to buy Cambridge Antibody Technology for 1,320 pence a share, valuing the UK biotech at 702 million pounds or about $1.32 billion.

12. 2007Apple

    The iPhone is introduced as a phone, widescreen iPod, and internet communicator, moving Apple into the center of mobile computing.

    The iPhone moved Apple into mobile computing and shifted the company's center of gravity away from the Mac. It also created the hardware base that later supported services, accessories and developer economics.

13. 2007AstraZeneca

    Acquisition of MedImmune for $15.6 Billion

    AstraZeneca acquires MedImmune for $15.6 billion, entering the biologics market and gaining the Synagis respiratory syncytial virus franchise and antibody technology platforms. The Gaithersburg facility becomes one of three global R&D centres.

14. 2008Apple

    The App Store opens with 500 apps, creating a controlled software marketplace that becomes a major Services pillar.

    The App Store launched with 500 apps and gave iPhone owners a single, controlled way to install third-party software.

15. 2011Apple

    Tim Cook becomes chief executive on August 24, 2011, after Steve Jobs resigns and the board names Cook to succeed him.

    Apple's board named Tim Cook chief executive on August 24, 2011, when Steve Jobs resigned and recommended the succession plan be carried out.

16. 2012AstraZeneca

    Pascal Soriot Appointed CEO

    Pascal Soriot joins AstraZeneca as Chief Executive Officer on October 1, 2012, with a base salary of $1.4 million and a mandate to reverse declining revenue and R&D productivity through science-led investment.

17. 2014Apple

    Apple agrees to acquire Beats Music and Beats Electronics for $3 billion, its largest deal.

    Apple agreed to buy Beats Music and Beats Electronics for a total of $3 billion, about $2.6 billion in purchase price plus roughly $400 million vesting over time, and brought in founders Jimmy Iovine and Dr. Dre.

18. 2014AstraZeneca

    Pfizer Hostile Takeover Rejected

    AstraZeneca's board rejects a $117 billion hostile takeover offer from Pfizer, with Soriot arguing that the undervaluation would destroy long-term shareholder value and pipeline potential.

19. 2014AstraZeneca

    Acquisition of Almirall Respiratory Portfolio

    AstraZeneca acquires the respiratory portfolio of Spanish pharmaceutical company Almirall for approximately $2.1 billion, strengthening the company's position in COPD and asthma with products including Eklira and pipeline candidates that become Breztri.

20. 2015AstraZeneca

    Tagrisso Approved for EGFR-Mutated Lung Cancer

    The FDA approves Tagrisso (osimertinib) in November 2015 for metastatic EGFR T790M mutation-positive non-small cell lung cancer, the first product from Soriot's reinvestment strategy to reach market.

21. 2017AstraZeneca

    Imfinzi Approved Based on PACIFIC Trial

    The FDA approves Imfinzi (durvalumab) for unresectable stage III non-small cell lung cancer after chemoradiation, based on PACIFIC trial data showing survival benefits.

22. 2020Apple

    Apple announces the Mac transition to Apple silicon, deepening control over performance, power efficiency, and software optimization.

    Apple began moving Mac computers off Intel processors and onto its own M-series chips in 2020.

23. 2020AstraZeneca

    COVID-19 Vaccine Development with Oxford University

    AstraZeneca partners with the University of Oxford to develop and manufacture the Vaxzevria COVID-19 vaccine, distributing billions of doses globally at nonprofit pricing during the pandemic peak.

24. 2021AstraZeneca

    Acquisition of Alexion Pharmaceuticals for $39 Billion

    AstraZeneca completes the $39 billion acquisition of Alexion on July 21, 2021, entering the rare disease market with Soliris and Ultomiris and creating a dedicated rare disease unit headquartered in Boston.

25. 2023AstraZeneca

    CinCor Pharma Acquired for up to $1.8 Billion

    AstraZeneca agrees on 9 January 2023 to acquire CinCor Pharma for up to $1.8 billion, $26 per share in cash plus a $10 per share contingent value right, to gain baxdrostat, an aldosterone synthase inhibitor for resistant hypertension.

26. 2024Apple

    Vision Pro launches at $3,499 and gives Apple a shipping platform for spatial interfaces, sensors, and custom silicon.

    Vision Pro gave Apple a live platform for spatial interfaces, eye and hand input, high-resolution displays and custom chips.

27. 2024AstraZeneca

    Total Revenue Reaches $54.073 Billion

    AstraZeneca reports Total Revenue of $54.073 billion for fiscal year 2024, an 18% increase at actual rates and 21% at constant exchange rates, with 16 blockbuster medicines, 74 regulatory events, and 24 pipeline progression events.

28. 2024AstraZeneca

    Fusion Pharmaceuticals and Gracell Acquisitions

    AstraZeneca acquires Fusion Pharmaceuticals for $2 billion to access radiopharmaceutical technology and Gracell Biotechnologies for $1.2 billion for cell therapy manufacturing, expanding modality diversity into radiopharmaceuticals and CAR-T.

29. 2025AstraZeneca

    Total Revenue Reaches $58.739 Billion

    AstraZeneca reports Total Revenue of $58.739 billion for fiscal year 2025, an 8% increase at constant exchange rates, with 16 positive Phase III readouts, 43 major market approvals, and a commitment to invest $50 billion in U.S. manufacturing by 2030.

30. 2025AstraZeneca

    EsoBiotec Acquired for Up to $1 Billion

    AstraZeneca acquires Belgian biotech EsoBiotec for up to $1 billion to access in vivo cell therapy technology, eliminating the need for ex vivo manufacturing in CAR-T therapies.

31. 2025AstraZeneca

    $50 Billion US Manufacturing and R&D Commitment

    AstraZeneca announces on 21 July 2025 that it will invest $50 billion in United States manufacturing and research by 2030, including a new Virginia facility later raised to $4.5 billion.

32. 2026Apple

    John Ternus becomes chief executive on September 1, 2026, and Tim Cook becomes executive chairman.

    John Ternus, Apple's senior vice president of Hardware Engineering, became chief executive on September 1, 2026, and Tim Cook became executive chairman after 15 years as CEO.

33. 2026AstraZeneca

    Ordinary Shares Begin Trading on the NYSE

    AstraZeneca ordinary shares start trading on the New York Stock Exchange on 2 February 2026 under the ticker AZN, after the American Depositary Share programme and certain debt securities stopped trading on Nasdaq on 30 January 2026.

34. 2026AstraZeneca

    Baxfendy Approved in the US for Hypertension

    The FDA approves Baxfendy (baxdrostat) in May 2026 as the first aldosterone synthase inhibitor for hypertension, used in combination with other antihypertensives in adults who are not adequately controlled.

35. 2026AstraZeneca

    $15 Billion China Investment Through 2030

    AstraZeneca announces on 29 January 2026 that it will invest $15 billion in China through 2030 to expand manufacturing and research, in a market that is its second largest and about 12% of revenue.

Acquisitions

Questions about Apple vs AstraZeneca